Growth Metrics

AtriCure (ATRC) Cash from Operations (2016 - 2025)

AtriCure (ATRC) has disclosed Cash from Operations for 16 consecutive years, with 20027000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 243.16% to 20027000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 57334000.0, a 369.8% increase, with the full-year FY2025 number at 57334000.0, up 369.8% from a year prior.
  • Cash from Operations was 20027000.0 for Q4 2025 at AtriCure, down from 26716000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 26716000.0 in Q3 2025 to a low of 24632000.0 in Q1 2022.
  • A 5-year average of 1905050.0 and a median of 911500.0 in 2021 define the central range for Cash from Operations.
  • Peak YoY movement for Cash from Operations: plummeted 668.97% in 2022, then surged 8660.87% in 2023.
  • AtriCure's Cash from Operations stood at 301000.0 in 2021, then crashed by 84.72% to 46000.0 in 2022, then soared by 8660.87% to 4030000.0 in 2023, then soared by 44.81% to 5836000.0 in 2024, then soared by 243.16% to 20027000.0 in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Cash from Operations are 20027000.0 (Q4 2025), 26716000.0 (Q3 2025), and 21617000.0 (Q2 2025).